Invasive Skin Melanoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-01-27
Clinical Trial Update: Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma [Phase 2]
Phase 2 clinical trial update evaluating multiple targeted therapies (capmatinib, ceritinib, regorafenib, or entrectinib) in patients with B…